Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies

Journal of Hematopathology(2020)10.1007/s12308-020-00417-5Source: DataRank Database

Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies is a research paper published in Journal of Hematopathology (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: bronzeTopics (20)IDs (OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Emasenyie Isikwei ORCID,Pragya Shrestha ORCID,Melissa R. Snyder ORCID,Brian Kabat,Kari G. Rabe ORCID

Live enrichment

OpenAlex:https://openalex.org/W3090786366

National Institutes of Health

Grant: 5T32GM008685-24

Training Grant in Clinical Pharmacology

FWCI

0.00

Citation Percentile

0.1%

Citation Trend

2024

2025

2026

bronzeLicense: Springer TDM

journalhttps://link.springer.com/content/pdf/10.1007/s12308-020-00417-5.pdf

BRONZEhttps://link.springer.com/content/pdf/10.1007/s12308-020-00417-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s12308-020-00417-5.pdf

publisherhttps://link.springer.com/article/10.1007/s12308-020-00417-5/fulltext.html

journalhttps://doi.org/10.1007/s12308-020-00417-5

Fields of Study

Chronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune DisordersBlood groups and transfusionMedicine03 medical and health sciences0302 clinical medicine

Keywords

HypogammaglobulinemiaMedicineChronic lymphocytic leukemiaInternal medicineCD20HematologyRituximabRetrospective cohort studyProportional hazards modelComplicationAntibodyGastroenterologyImmunologyLeukemia

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being